{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:21Z","timestamp":1707524841543},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"DOI":"10.7759\/cureus.32870","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T15:58:01Z","timestamp":1671811081000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Multifocal Leukoencephalopathy Associated With Idiopathic CD8+ Lymphocytopenia"],"prefix":"10.7759","author":[{"given":"Marta","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do C\u00e9u","family":"D\u00f3ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"R\u00eago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Valido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic D","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015, 8:255-73. 10.1177\/1756285615602832","journal-title":"Ther Adv Neurol Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0363-8","article-title":"Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate","volume":"15","author":"Dammeier N","year":"2015","unstructured":"Dammeier N, Schubert V, Hauser TK, Bornemann A, Bischof F. Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate. BMC Neurol. 2015, 15:108. 10.1186\/s12883-015-0363-8","journal-title":"BMC Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7071.1","article-title":"Progressive multifocal leukoencephalopathy","volume":"4","author":"Adang L","year":"2015","unstructured":"Adang L, Berger J. Progressive multifocal leukoencephalopathy. F1000Res. 2015, 4:10.12688\/f1000research.7071.1","journal-title":"F1000Res"},{"key":"ref4","article-title":"Progressive Multifocal Leukoencephalopathy","author":"Saji AM","year":"2022","unstructured":"Saji AM, Gupta V. Progressive Multifocal Leukoencephalopathy. StatPearls, Treasure Island; 2022."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1041-4","article-title":"Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review","volume":"18","author":"Ueno T","year":"2018","unstructured":"Ueno T, Sato N, Kon T, et al.. Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review. BMC Neurol. 2018, 18:37. 10.1186\/s12883-018-1041-4","journal-title":"BMC Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab treatment for progressive multifocal leukoencephalopathy","volume":"380","author":"Cortese I","year":"2019","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, et al.. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019, 380:1597-605. 10.1056\/NEJMoa1815039","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001021","article-title":"Single-dose pembrolizumab treatment for progressive multifocal leukoencephalopathy","volume":"8","author":"Beudel M","year":"2021","unstructured":"Beudel M, R\u00f6vekamp F, van de Beek D, Brouwer M. Single-dose pembrolizumab treatment for progressive multifocal leukoencephalopathy. Neurol Neuroimmunol Neuroinflamm. 2021, 8:10.1212\/NXI.0000000000001021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger JR","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, et al.. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013, 80:1430-8. 10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-011-0045-2","article-title":"Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS","volume":"17","author":"McGuire JL","year":"2011","unstructured":"McGuire JL, Fridman V, W\u00fcthrich C, Koralnik IJ, Jacobs D. Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS. J Neurovirol. 2011, 17:500-3. 10.1007\/s13365-011-0045-2","journal-title":"J Neurovirol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.2.169","article-title":"Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions","volume":"64","author":"St\u00fcve O","year":"2007","unstructured":"St\u00fcve O, Marra CM, Cravens PD, et al.. Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Arch Neurol. 2007, 64:169-76. 10.1001\/archneur.64.2.169","journal-title":"Arch Neurol"},{"key":"ref11","article-title":"The benefit of mirtazapine in the treatment of progressive multifocal leukoencephalopathy in a young HIV-positive patient: a case report","volume":"15","author":"Mullins C","year":"2018","unstructured":"Mullins C, Miranda J, Sandoval H, Ramos-Duran L, Tonarelli SB. The benefit of mirtazapine in the treatment of progressive multifocal leukoencephalopathy in a young HIV-positive patient: a case report. Innov Clin Neurosci. 2018, 15:33-5.","journal-title":"Innov Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127665-progressive-multifocal-leukoencephalopathy-associated-with-idiopathic-cd8-lymphocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:46Z","timestamp":1707508006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127665-progressive-multifocal-leukoencephalopathy-associated-with-idiopathic-cd8-lymphocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.32870","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}